Ticker > Company >

Indrayani Biotech share price

Indrayani Biotech Ltd.

BSE: 526445 SECTOR: Floriculture  18k   37   1

13.83
+0.03 (0.22%)
BSE: Today, 04:00 PM

Price Summary

Today's High

₹ 13.99

Today's Low

₹ 13.01

52 Week High

₹ 62.71

52 Week Low

₹ 13.50

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

62.98 Cr.

Enterprise Value

121.31 Cr.

No. of Shares

4.55 Cr.

P/E

43.56

P/B

1.14

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  12.15

CASH

0.26 Cr.

DEBT

58.60 Cr.

Promoter Holding

33.28 %

EPS (TTM)

₹  0.32

Sales Growth

-16.32%

ROE

3.21 %

ROCE

7.99%

Profit Growth

-71.18 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-16.32%
3 Year43.69%
5 Year∞%

Profit Growth

1 Year-71.18%
3 Year28.74%
5 Year96.14%

ROE%

1 Year3.21%
3 Year12.68%
5 Year-15.2%

ROCE %

1 Year7.99%
3 Year12.16%
5 Year-2.83%

Debt/Equity

1.16

Price to Cash Flow

2.41

Interest Cover Ratio

1.61

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 33.28 24.61
Dec 2024 33.28 18.08
Sep 2024 33.40 15.06
Jun 2024 33.48 15.02
Mar 2024 33.57 14.98
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 28.74% for the Past 3 years.
  • The company has shown a good revenue growth of 43.69% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of 87.88 days.

 Limitations

  • Promoter pledging has increased from 18.08% to 24.61% in 1 quarter.
  • The company has a low EBITDA margin of -4.26% over the past 5 years.
  • The company is trading at a high PE of 43.56.
  • Promoter pledging is high as 24.61%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 15.80 10.79 9.51 8.19 9.28
Total Expenditure 14.79 9.81 8.07 6.86 7.56
Operating Profit 1.01 0.98 1.44 1.33 1.73
Other Income 3.45 1.03 0.89 0.66 0.93
Interest 2.47 1.52 1.89 1.53 2.40
Depreciation 0.36 0.32 0.32 0.32 0.06
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.62 0.17 0.13 0.14 0.20
Tax 1.55 0.04 0.03 0.04 -0.91
Profit After Tax 0.07 0.13 0.10 0.11 1.11
Adjusted EPS (Rs) 0.02 0.03 0.02 0.02 0.24

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0.50 21.01 57.99 74.48 62.32
Total Expenditure 0.66 25.68 51.75 65.76 56.52
Operating Profit -0.15 -4.67 6.24 8.72 5.80
Other Income 0 0.26 0.22 0.64 3.62
Interest 0.05 1.97 1.89 2.85 4.96
Depreciation 0 0.40 0.34 0.93 1.45
Exceptional Items 0 -4.11 0 -0.50 0
Profit Before Tax -0.21 -10.89 4.23 5.08 3.01
Tax 0 0 0 0.02 1.55
Net Profit -0.21 -10.89 4.23 5.06 1.46
Adjusted EPS (Rs.) -0.56 -3.18 1.23 1.48 0.32

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.64 34.23 34.23 43.48 45.54
Total Reserves -4.50 -14.28 -10.05 7.67 8.98
Borrowings 0.69 8.15 6.79 9.76 14.88
Other N/C liabilities 0 0.01 0.01 6.33 5.09
Current liabilities 0.39 11.73 18.46 33.06 51.52
Total Liabilities 0.22 39.85 49.43 100.30 126.01
Assets
Net Block 0 15.11 15.33 23.81 21.66
Capital WIP 0 13.72 13.22 12.72 18.03
Intangible WIP 0 0 0 0 0
Investments 0 0.19 0.19 7.99 9.56
Loans & Advances 0 0.47 2.03 6.46 5.26
Other N/C Assets 0 1.33 0.68 0 0
Current Assets 0.22 9.04 17.99 49.33 71.50
Total Assets 0.22 39.85 49.43 100.30 126.01
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -0.21 -10.89 4.23 5.06 3.01
Adjustment 0.05 4.47 2.21 4.18 6.23
Changes in Assets & Liabilities 0.23 6.94 -2.97 -0.91 16.85
Tax Paid 0 0 0 0 0
Operating Cash Flow 0.08 0.52 3.47 8.33 26.09
Investing Cash Flow 0 -0.56 0.59 -14.09 -7.26
Financing Cash Flow 0 -0.73 -3.23 4.93 -19.19
Net Cash Flow 0.08 -0.78 0.82 -0.83 -0.36

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 33.57 33.48 33.40 33.28 33.28
g swaminathan - - - 9.09 9.09
i umasundari - - - 4.61 4.61
jothi ramesh - - - 2.31 2.31
m ramesh - - - 2.31 2.31
s i dinesh kumar - - - 1.54 1.54
s indirakumar - - - 4.61 4.61
sayee sundar kasiraman 5.78 5.78 5.78 5.78 5.78
thirumeni thiruselvaraja - - - 1.71 1.71
v agathiyan - - - 1.33 1.33
g swaminathan . 9.09 9.09 9.09 - -
i umasundari . 4.61 4.61 4.61 - -
jothi ramesh . 2.31 2.31 2.31 - -
m ramesh . 2.31 2.31 2.31 - -
s i dinesh kumar . 1.54 1.54 1.54 - -
s indirakumar . 4.61 4.61 4.61 - -
thirumeni thiruselvaraja ... 1.85 1.81 1.76 - -
v agathiyan . 1.47 1.43 1.39 - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 66.43 66.52 66.60 66.72 66.72
ajitkumar c patel 2.42 2.85 2.85 2.85 2.85
dheeraj kumar lohia - - 2.05 2.05 2.40
jayaseelan singaravelu - 10.14 10.00 10.00 10.11
karuppannan a - - - - 1.28
llp 0.21 0.23 0.25 0.25 0.21
lrsd securities pvt ltd - - - - 1.54
malarvannan subashini 2.33 2.33 2.33 2.33 2.33
rajasthan global securiti... - 2.73 3.06 3.06 1.57
s prakash 1.71 1.71 1.71 1.71 1.71
sonal lohia - - - - 1.17
sridhar muthuraman - 2.20 2.20 2.20 2.20
next orbit ventures fund 6.75 4.07 2.53 2.19 -
r raja - - - 1.12 -
r raja . 2.37 2.37 1.12 - -
geetha kannan - 1.10 - - -
sridhar 2.20 - - - -

Annual Reports

Title Link
Annual Report 2024
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
No Credit reports exist for this company.Report us
TYPE AGENCY Link
No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
Currently we do not have any Presentation related to this company.Report us

Company News

 No Latest News available for this company.
Report us

Indrayani Biotech Stock Price Analysis and Quick Research Report. Is Indrayani Biotech an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Indrayani Biotech has a PE ratio of 43.56 which is high and comparatively overvalued .

  • Share Price: - The current share price of Indrayani Biotech is Rs 13.83. One can use valuation calculators of ticker to know if Indrayani Biotech share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Indrayani Biotech has ROA of 1.29 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Indrayani Biotech has a Current ratio of 1.39 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Indrayani Biotech has a ROE of 3.21 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Indrayani Biotech has a D/E ratio of 1.16 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Indrayani Biotech has an Inventory turnover ratio of 32.91 which shows that the management is efficient in relation to its Inventory and working capital management.

  • Sales growth: - Indrayani Biotech has reported revenue growth of -16.32 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Indrayani Biotech for the current financial year is 9.31 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Indrayani Biotech is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Indrayani Biotech
X